More often than not, when talk in New Jersey turns to the pharmaceutical industry tones turn serious and the discussion centers around whether pharma will continue to support the state’s economy in the way it has for more than a century.
What most observers don’t realize is that New Jersey can rightfully call itself the undisputed global leader in biopharmaceuticals, a subset of the pharma industry hailed as key to its future.
